BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Rating) reached a new 52-week high on Wednesday . The company traded as high as $3.20 and last traded at $3.13, with a volume of 1074 shares trading hands. The stock had previously closed at $2.95.

BioRestorative Therapies Stock Down 4.1 %

The firm has a market cap of $4.92 billion, a PE ratio of -6.56 and a beta of 102.36. The stock has a 50-day simple moving average of $2.98 and a two-hundred day simple moving average of $3.10.

BioRestorative Therapies Company Profile

(Get Rating)

BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company's two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.

Recommended Stories

• Get a free copy of the StockNews.com research report on BioRestorative Therapies (BRTXQ)
• Exxon Mobil Stock: Within Striking Distance Of Buy Point
• High-Dividend-Yielding BHP Sees China Driving '23 Growth
• Is Airbnb Setting Up To Rally 38%, As Analysts Are Forecasting?
• Does a Price Cut for Tesla Vehicles Mean the Same for TSLA Stock?
• Microsoft Layoffs Signal Layoffs for Other Tech Companies?

Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.